299 related articles for article (PubMed ID: 24105892)
1. Pharmacogenetics in cardiovascular disease: the challenge of moving from promise to realization: concepts discussed at the Canadian Network and Centre for Trials Internationally Network Conference (CANNeCTIN), June 2009.
Joseph PG; Pare G; Ross S; Roberts R; Anand SS
Clin Cardiol; 2014 Jan; 37(1):48-56. PubMed ID: 24105892
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular pharmacogenomics and individualized drug therapy.
Pereira NL; Weinshilboum RM
Nat Rev Cardiol; 2009 Oct; 6(10):632-8. PubMed ID: 19707183
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular drugs and the genetic response.
Dandona S
Methodist Debakey Cardiovasc J; 2014; 10(1):13-7. PubMed ID: 24932357
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics and cardiovascular disease--implications for personalized medicine.
Johnson JA; Cavallari LH
Pharmacol Rev; 2013 Jul; 65(3):987-1009. PubMed ID: 23686351
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of chronic cardiovascular drugs: applications and implications.
Zineh I; Johnson JA
Expert Opin Pharmacother; 2006 Aug; 7(11):1417-27. PubMed ID: 16859425
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics and cardiovascular disease: impact on drug response and applications to disease management.
Humma LM; Terra SG
Am J Health Syst Pharm; 2002 Jul; 59(13):1241-52. PubMed ID: 12116890
[TBL] [Abstract][Full Text] [Related]
7. Use of Pharmacogenetic Information in the Treatment of Cardiovascular Disease.
Friede K; Li J; Voora D
Clin Chem; 2017 Jan; 63(1):177-185. PubMed ID: 27864383
[TBL] [Abstract][Full Text] [Related]
8. Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.
Zaiou M; Benachour H; Marteau JB; Visvikis-Siest S; Siest G
Curr Pharm Des; 2009; 15(27):3193-206. PubMed ID: 19754391
[TBL] [Abstract][Full Text] [Related]
9. An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers.
Oni-Orisan A; Tuteja S; Hoffecker G; Smith DM; Castrichini M; Crews KR; Murphy WA; Nguyen NHK; Huang Y; Lteif C; Friede KA; Tantisira K; Aminkeng F; Voora D; Cavallari LH; Whirl-Carrillo M; Duarte JD; Luzum JA;
Clin Pharmacol Ther; 2023 Aug; 114(2):275-287. PubMed ID: 37303270
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
Zaiou M; El Amri H
Clin Genet; 2017 Mar; 91(3):355-370. PubMed ID: 27714756
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of cardiovascular drugs.
Saleh A; Al-Abcha A; Pereira N
Curr Opin Cardiol; 2023 May; 38(3):207-214. PubMed ID: 37016993
[TBL] [Abstract][Full Text] [Related]
12. Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments.
Berinstein E; Levy A
Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):973-983. PubMed ID: 28792790
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics in Cardiovascular Medicine.
Weeke PE
Adv Pharmacol; 2018; 83():333-360. PubMed ID: 29801582
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of heart failure: evidence, opportunities, and challenges for cardiovascular pharmacogenomics.
Wheeler MT; Ho M; Knowles JW; Pavlovic A; Ashley EA
J Cardiovasc Transl Res; 2008 Mar; 1(1):25-36. PubMed ID: 20559955
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular pharmacogenetics of anti-thrombotic agents and non-steroidal anti-inflammatory drugs.
Stitham J; Vanichakarn P; Ying L; Hwa J
Curr Mol Med; 2014; 14(7):909-31. PubMed ID: 25109796
[TBL] [Abstract][Full Text] [Related]
17. Use of pharmacogenomics in elderly patients treated for cardiovascular diseases.
Božina N; Vrkić Kirhmajer M; Šimičević L; Ganoci L; Mirošević Skvrce N; Klarica Domjanović I; Merćep I
Croat Med J; 2020 Apr; 61(2):147-158. PubMed ID: 32378381
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular pharmacogenomics.
Roden DM; Johnson JA; Kimmel SE; Krauss RM; Medina MW; Shuldiner A; Wilke RA
Circ Res; 2011 Sep; 109(7):807-20. PubMed ID: 21921273
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine.
Nakagawa K; Ishizaki T
Pharmacol Ther; 2000 Apr; 86(1):1-28. PubMed ID: 10760544
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics: the way forward.
Terra SG; Johnson JA
Am J Cardiovasc Drugs; 2002; 2(5):287-96. PubMed ID: 14727958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
